{"retracted":false,"update":{"timestamp":1479945600000,"doi":"10.1007/s12325-016-0442-2","type":"correction"},"doi":"10.1007/s12325-016-0327-4","journal":"Advances in Therapy","publisher":"Springer Nature","title":"Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial"}
